European Review for Medical and Pharmacological Sciences
Overview
The European Review for Medical and Pharmacological Sciences is a reputable journal that publishes high-quality research articles, reviews, and case reports in the field of medicine and pharmacology. It covers a wide range of topics including clinical trials, drug development, disease management, and therapeutic interventions. With a focus on European research, this journal serves as a valuable resource for healthcare professionals, researchers, and policymakers seeking the latest advancements in medical and pharmacological sciences.
Details
Details
Abbr.
Eur Rev Med Pharmacol Sci
Start
1997
End
Continuing
Frequency
Biweekly, Oct. 2012-
p-ISSN
1128-3602
e-ISSN
2284-0729
Country
Italy
Language
English
Specialties
General Medicine
Pharmacology
Toxicology
Pharmacology
Toxicology
Metrics
Metrics
h-index / Ranks: 3798
88
SJR / Ranks: 7781
580
CiteScore / Ranks: 3528
6.30
JIF / Ranks: 3040
3.3
Recent Articles
1.
Swiatkowski F, Buldys K, Gornicki T, Jurga M, Chabowski M
Eur Rev Med Pharmacol Sci
. 2025 Mar;
29(2):86-96.
PMID: 40026139
Objective: Colorectal cancer continues to be a serious health problem in developed countries. Since the incidence of this cancer is constantly increasing, it is currently the subject of numerous studies....
2.
Saucedo-Sarinana A, Barros-Nunez P, Pineda-Razo T, Marin-Contreras M, Contreras-Diaz K, Juarez-Vazquez C, et al.
Eur Rev Med Pharmacol Sci
. 2025 Mar;
29(2):74-85.
PMID: 40026138
Objective: MicroRNAs (miRNAs) are non-coding RNAs that participate actively in the post-transcriptional regulation of tumor suppressors, oncogenes, and DNA repair genes implicated in colorectal cancer (CRC). MiRNAs have been promising...
3.
Pesare E, Maccagnano G, Vicenti G, Caruso I, Di Gioia L, Coviello M, et al.
Eur Rev Med Pharmacol Sci
. 2025 Mar;
29(2):67-73.
PMID: 40026137
Objective: The diagnosis of euthyroid sick syndrome (ESS) in several diseases has been associated with poor outcomes, and proximal femur fractures are among the most common injuries in elderly patients,...
4.
Pezzuto A, Ricci A, Palermo T, Salvucci C, Pelosi G, Stirpe F, et al.
Eur Rev Med Pharmacol Sci
. 2025 Mar;
29(2):97-101.
PMID: 40026136
Background: Immunotherapy is a widely used and effective therapy for lung malignancy. However, its acting on the immune system can cause several adverse effects. Case Report: This is a case...
5.
Shaheen A, Alenazi Y, Albarrati A, Alnahdi A, Alsubiheen A, Alrashed F, et al.
Eur Rev Med Pharmacol Sci
. 2025 Mar;
29(2):53-66.
PMID: 40026135
Objective: The multidimensional dyspnea profile (MDP) is a self-reported instrument validated in several languages but not Arabic. The study aimed to translate and cross-culturally adapt the MDP into Arabic (A-MDP)...
6.
Schmitz S, Alvarez-Vaca D, Weiss J, Pires S, Masi S, Debacker M, et al.
Eur Rev Med Pharmacol Sci
. 2025 Feb;
29(1):39-52.
PMID: 39911045
Objective: Burden of disease studies evaluate the direct impact of disease in terms of morbidity and premature mortality over a given time horizon. The objective of this study was to...
7.
Parker B, Proctor K, Guerra R, Manning R, Aguilar V, Meizoso J, et al.
Eur Rev Med Pharmacol Sci
. 2025 Feb;
29(1):30-38.
PMID: 39911044
Objective: Antithrombin (AT) has anti-inflammatory and anti-coagulant properties, but its role in COVID-19 and the rate of deficiency is unknown. We hypothesize that AT3 deficiency is common in COVID-19, and...
8.
Ricci C, Di Pumpo M, Nicolotti N, Capelli G, Zannoni G, Evangelista M, et al.
Eur Rev Med Pharmacol Sci
. 2025 Feb;
29(1):23-29.
PMID: 39911043
Objective: Cervical cancer is known as one of the most common malignant tumors in the female population. It can be prevented by early detection and treatment of cervical intraepithelial neoplasia...
9.
de Castro Cardoso Toniasso S, Borba Brum M, Lopes Dos Reis F, Calvi Sampaio V, Pereira da Silva L, Martins Pereira R, et al.
Eur Rev Med Pharmacol Sci
. 2025 Feb;
29(1):12-22.
PMID: 39911042
Objective: Pesticide use is disseminated worldwide. It plays a major role in expanding agribusiness and poses a serious threat to the health of the population through various forms of exposure...
10.
Becker M, Kist A, Wendler O, Pesold V, Bleier B, Mueller S
Eur Rev Med Pharmacol Sci
. 2025 Feb;
29(1):1-11.
PMID: 39911041
Objective: Chronic rhinosinusitis (CRS) has traditionally been classified phenotypically according to the presence (CRSwNP) or absence (CRSsNP) of nasal polyps. However, the phenotypic dichotomy does not represent the complexity of...